Inactive Instrument

Esperite N.V.

Equities

ESP

NL0009272137

Healthcare Facilities & Services

The Cell-Factory BVBA announced that it expects to receive funding from Esperite N.V.

November 28, 2018

The Cell-Factory BVBA announced a private placement of series A round funding on November 29, 2018. The company expects to close the transaction in Q1 2019. The transaction involved participation Esperite N.V. (ENXTAM:ESP).

Latest news about Esperite N.V.

Esperite N.V. announced that it expects to receive €35 million in funding	20-07-27	CI
Esperite N.V. and Myrisoph Capital Conclude a Strategic Agreement on Cryo-Save’s Family Stem Cell Banking Business	19-08-27	CI
Esperite N.V. Reports Earnings Results for the Half Year Ended June 30, 2018	19-06-30	CI
Esperite Resumes Takeover Talks With Polski Bank Komorek Business	19-06-13	CI
Esperite NV Introduces Jouvene - Swiss Medicine Quintessence, the First Combined Offer of Stem Cell Long Term Storage and Highly Accurate Whle Genome Sequencing for Consumer Distribution	19-06-04	CI
Polski Bank Komórek Macierzystych S.A. cancelled the acquisition of Cryo-Save Family Stem Cell Banking business from Esperite N.V..	19-05-27	CI
Polski Bank Komórek Macierzystych S.A. entered into a memorandum of understanding to acquire Cryo-Save Family Stem Cell Banking business from Esperite N.V. for €10 million.	19-02-21	CI
The Cell-Factory BVBA announced that it expects to receive funding from Esperite N.V.	18-11-28	CI
Esperite N.V. Reports Consolidated Earnings Results for the Year Ended December 31, 2017	18-11-23	CI
Go Life Healthcare Limited cancelled the acquisition of Cryo-Save South Africa Ltd., from Esperite N.V..	18-10-02	CI
Esperite N.V. with Cryosave Stores More Than A Million Samples in its New Designed Cryostorage Facility in Geneva	18-09-13	CI
Go Life Healthcare Limited agreed to acquire Cryo-Save South Africa Ltd., from Esperite N.V. for ZAR 20 million.	18-07-01	CI
Esperite N.V. announced that it expects to receive €5 million in funding from L1 Capital Pty Limited	18-06-11	CI
Esperite N.V. Launches New AGAATA Diagnostic System with Machine Learning Capabilities for Genetic Clinical Laboratories	18-06-06	CI
Esperite N.V. acquired the remaining 50% stake in CryoSave South Africa Ltd from Ecsponent Limited.	18-05-15	CI
Esperite N.V Receives European Funding to Develop Second Generation EVs Drug for Treatment of Stroke	18-05-03	CI
Esperite and BGI Genomics Sign Strategic Agreement to Offer Whole Genome Sequencing on Large Scale	18-01-31	CI
Frederic Amar acquired CryoSave Labs from Esperite N.V..	18-01-09	CI
Esperite N.V. announced that it has received €0.4 million in funding	18-01-04	CI
Esperite N.V. Announces Consolidated Earnings Results for the Year Ended December 31, 2016	17-05-23	CI
Esperite N.V. announced that it expects to receive €9 million in funding from L1 Capital Pty Limited	17-03-07	CI
Esperite N.V. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016	16-08-23	CI
Esperite N.V. Auditor Raises 'Going Concern' Doubt	16-04-28	CI
Esperite N.V. Announces Consolidated Earnings Results for the Year Ended December 31, 2015	16-04-28	CI
Esperite N.V.(ENXTAM:ESP) dropped from Netherlands ASCX AMS Small Cap Index	16-03-30	CI

Chart Esperite N.V.

Duration

Period

More charts

Company Profile

Esperite N.V. is an investment company specialized in equity participations in companies operating in the health and biotechnology sectors.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
EUROFINS SCIENTIFIC SE	-3.97%	11.66B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
PURE HEALTH HOLDING	-31.75%	11.77B

Other Healthcare Facilities & Services